Acrobat Genomics
PrivateLast Round
Grant
Apr 29, 2026
Total Funding Raised
$228,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Acrobat Genomics operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Seed round in December 2022.
Acrobat Genomics is a biotechnology company that develops a drug discovery platform using AI and high-throughput CRISPR gene-editing precision technology to create new therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acrobat Genomics Comparables
Compare Acrobat Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cassidy Bio | 78% | |
| Profluent Bio | 71% | |
| Arbor Biotechnologies | 71% |
For institutional investors. Book with your work email.
Acrobat Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 29, 2026 | ||||
| Seed | Dec 12, 2022 | ||||
| Accelerator | Sep 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Acrobat Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| NIH RADx | Grant |
| First In | Seed |
| Defense Advanced Research Projects Agency | Grant |
| Reinforced Ventures | Seed |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 2, 4x the trailing average.
- Apr 29, 2026
Received funding from the Defense Advanced Research Projects Agency.
For institutional investors. Book with your work email.
Acrobat Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acrobat Genomics's valuation, stock price, and market status.
Is Acrobat Genomics a public or private company?
Acrobat Genomics is a private company.
What is the current stock price of Acrobat Genomics?
Acrobat Genomics is a private company, so its shares have no public market price. Caplight tracks Acrobat Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acrobat Genomics worth (valuation)?
Valuation information for Acrobat Genomics is not publicly available.
Can I buy Acrobat Genomics stock?
Acrobat Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acrobat Genomics's last funding round?
Acrobat Genomics's most recent funding round was Grant on April 29, 2026.
Who are the main investors in Acrobat Genomics?
Key investors in Acrobat Genomics include Illumina Accelerator.
Will Acrobat Genomics IPO soon?
No public IPO plans have been announced for Acrobat Genomics.
How can I track Acrobat Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Acrobat Genomics's shares on secondary markets.